Literature DB >> 1825450

In vivo collagen turnover during development of thyroxine-induced left ventricular hypertrophy.

M A Karim1, A G Ferguson, B T Wakim, A M Samarel.   

Abstract

Cardiac fibroblasts synthesize large amounts of procollagens, yet only a small fraction of mature collagens accumulate in the extracellular matrix. To determine the roles of intracellular degradation of newly synthesized procollagens and extracellular degradation of mature collagens during normal growth and during thyroxine-induced left ventricular hypertrophy, in vivo left ventricular procollagen synthetic rates were assessed in control rats and rats treated with L-thyroxine for 1, 2, 4, and 8 wk (1 mg.kg-1.day-1). A modification of the flooding infusion method was developed using measurements of cardiac prolyl-tRNA, and tissue-free and protein-bound hydroxyproline specific radioactivities 60 min after intravenous administration of a massive dose of [3H]proline. Degradative rates of newly synthesized procollagens and mature collagens were then derived as the difference between rates of procollagen synthesis and collagen accumulation. Left ventricular procollagen synthetic rates were markedly increased after 1 wk of hormone administration (256 +/- 16 and 166 +/- 13 micrograms/day per left ventricle for thyroxine-treated and control animals, respectively; P less than 0.01). An even greater increase in procollagen synthetic rates was observed after 8 wk (438 +/- 46 and 202 +/- 18 micrograms/day for thyroxine-treated and control animals, respectively; P less than 0.01). Despite increased procollagen synthesis, disproportionate accumulation of fibrillar collagens (assessed as the relative concentration of protein-bound hydroxyproline in left ventricular tissue) did not occur. Derived left ventricular degradative rates for newly synthesized procollagens as well as for mature collagens were increased in thyroxine-treated animals. Increased procollagen synthesis, enhanced flux of newly synthesized procollagens through intracellular degradative pathways, and extensive extracellular matrix remodeling without disproportionate collagen accumulation are characteristics of this form of "physiological" left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825450     DOI: 10.1152/ajpcell.1991.260.2.C316

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  In vivo measurements of the contributions of protein synthesis and protein degradation in regulating cardiac pressure overload hypertrophy in the mouse.

Authors:  Paul J McDermott; Catalin F Baicu; Shaun R Wahl; An O Van Laer; Michael R Zile
Journal:  Mol Cell Biochem       Date:  2012-05-19       Impact factor: 3.396

2.  Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure.

Authors:  Yevgeniya E Koshman; Nilamkumar Patel; Miensheng Chu; Rekha Iyengar; Taehoon Kim; Cagatay Ersahin; William Lewis; Alain Heroux; Allen M Samarel
Journal:  J Card Fail       Date:  2013-03-19       Impact factor: 5.712

3.  Regulation of procollagen metabolism in the pressure-overloaded rat heart.

Authors:  E G Eleftheriades; J B Durand; A G Ferguson; G L Engelmann; S B Jones; A M Samarel
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

4.  Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.

Authors:  Anthony Atala; Darrell J Irvine; Marsha Moses; Sunil Shaunak
Journal:  MRS Bull       Date:  2010-08-01       Impact factor: 6.578

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.